Bank Of New York Mellon Corp Alnylam Pharmaceuticals, Inc. Transaction History

Bank Of New York Mellon Corp

$521 Trillion
Q1 2024

A detailed history of Bank Of New York Mellon Corp transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Bank Of New York Mellon Corp holds 798,445 shares of ALNY stock, worth $119 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

798,445

Previous 837,131 4.62%

Holding current value

$119 Million

Previous $160 Billion 25.53%

% of portfolio

0.02%

Previous 0.03%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	SELL	$146.51 - $198.2 $5.67 Million - $7.67 Million	-38,686 Reduced 4.62%	798,445 $119 Billion
Q4 2023 Jan 29, 2024	BUY	$151.41 - $196.57 $7,116 - $9,238	47 Added 0.01%	837,131 $160 Billion
Q3 2023 Oct 24, 2023	BUY	$170.77 - $211.65 $10.5 Million - $13 Million	61,488 Added 7.93%	837,084 $148 Billion
Q2 2023 Aug 03, 2023	BUY	$185.01 - $212.05 $40.9 Million - $46.9 Million	221,259 Added 39.91%	775,596 $147 Billion
Q1 2023 May 09, 2023	BUY	$182.66 - $235.53 $101 Million - $131 Million	554,337 New	554,337 $111 Billion

Q4 2022 Feb 14, 2023	BUY	$185.53 - $241.31 $107 Million - $139 Million	574,385 New	574,385 $137 Million
Q3 2022 Nov 14, 2022	SELL	$138.54 - $232.0 $15 Million - $25.1 Million	-108,017 Reduced 16.0%	567,138 $114 Million
Q2 2022 Aug 15, 2022	BUY	$120.42 - $169.29 $4.37 Million - $6.14 Million	36,287 Added 5.68%	675,155 $98.5 Million
Q1 2022 May 11, 2022	BUY	$127.18 - $173.91 $4.65 Million - $6.36 Million	36,554 Added 6.07%	638,868 $104 Million
Q4 2021 Feb 11, 2022	BUY	$159.56 - $209.29 $23.8 Million - $31.2 Million	149,064 Added 32.89%	602,314 $102 Million
Q3 2021 Nov 12, 2021	BUY	$169.75 - $207.73 $1.91 Million - $2.34 Million	11,249 Added 2.55%	453,250 $85.6 Million
Q2 2021 Aug 11, 2021	BUY	$128.63 - $176.89 $2.6 Million - $3.57 Million	20,187 Added 4.79%	442,001 $74.9 Million
Q1 2021 May 13, 2021	SELL	$126.83 - $175.69 $2.65 Million - $3.67 Million	-20,874 Reduced 4.72%	421,814 $59.6 Million
Q4 2020 Feb 09, 2021	BUY	$122.97 - $147.0 $950,927 - $1.14 Million	7,733 Added 1.78%	442,688 $57.5 Million
Q3 2020 Nov 12, 2020	BUY	$121.19 - $165.49 $21,814 - $29,788	180 Added 0.04%	434,955 $63.3 Million
Q2 2020 Aug 12, 2020	SELL	$104.21 - $156.44 $884,638 - $1.33 Million	-8,489 Reduced 1.92%	434,775 $64.4 Million
Q1 2020 May 06, 2020	BUY	$93.12 - $133.99 $104,387 - $150,202	1,121 Added 0.25%	443,264 $48.2 Million
Q4 2019 Feb 14, 2020	SELL	$74.51 - $124.23 $637,805 - $1.06 Million	-8,560 Reduced 1.9%	442,143 $50.9 Million
Q3 2019 Nov 07, 2019	BUY	$70.9 - $87.82 $3.55 Million - $4.39 Million	50,010 Added 12.48%	450,703 $36.2 Million
Q2 2019 Aug 12, 2019	BUY	$65.86 - $92.79 $691,200 - $973,831	10,495 Added 2.69%	400,693 $29.1 Million
Q1 2019 May 14, 2019	SELL	$72.76 - $93.45 $7.7 Million - $9.89 Million	-105,795 Reduced 21.33%	390,198 $36.5 Million
Q4 2018 Feb 11, 2019	SELL	$62.67 - $88.33 $1.01 Million - $1.43 Million	-16,177 Reduced 3.16%	495,993 $36.2 Million
Q3 2018 Nov 09, 2018	BUY	$87.52 - $122.67 $18,291 - $25,638	209 Added 0.04%	512,170 $0
Q2 2018 Aug 06, 2018	BUY	$88.31 - $107.8 $10 Million - $12.3 Million	113,650 Added 28.53%	511,961 $50.4 Million
Q1 2018 May 15, 2018	BUY	$115.92 - $148.54 $352,860 - $452,155	3,044 Added 0.77%	398,311 $47.4 Million
Q4 2017 Feb 09, 2018	BUY	$114.49 - $139.98 $45.3 Million - $55.3 Million	395,267	395,267 $50.2 Million

Others Institutions Holding ALNY

# of Institutions

584

Shares Held

104M

Call Options Held

2.82M

Put Options Held

1.75M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $18.4B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account

Bank Of New York Mellon Corp Alnylam Pharmaceuticals, Inc. Transaction History